The Biomedical Advanced Research and Development Authority (BARDA) is responsible for the U.S. government's procurement and advanced development of medical countermeasures for chemical, biological, radiological and nuclear agents for the civilian population, based on threats identified in Department of Homeland Security Material Threat Determinations. BARDA is funding advanced development and/or procurement of countermeasures for three of the 12 biological agents identified by DHS, as well as broad spectrum antimicrobials (BSA), which could, in